2020-10-12 Sylvi Irawati
Prof dr E Hak
Prof dr K. Taxis
Challenges in the use of preventive cardiovascular medications in Indonesia and the Netherlands
2020-10-06 Sofa Alfian
Prof dr E Hak
Prof dr P. Denig
Adherence to antihypertensive or antihyperlipidemic co-medications in diabetes: patterns, predictors and intervention
2020-05-08 Yuanyuan Wang
Prof dr E Hak
Prof dr M Boezen
Effectiveness and safety of medicines used in COPD patients: pharmacoepidemiological studies
2020-02-24 Ivan Pradipta
Prof de E Hak
Prof dr JW Alffenaar
Improving treatment outcomes of tuberculosis: towards an antimicrobial stewardship program
2020-02-10 Ira Sianturi
Prof dr K Taxis
Prof dr B Wilffert
Exploring strategies to optimize pharmacotherapy with antiretrovirals in Papuans living with HIV
2019-03-22 Heleen van der Meer
Prof dr K Taxis
Prof dr LG Pont
Describing in older people. Development and evaluation of complex healthcare interventions
2018-12-21 Willem van der Veen
Prof dr K Taxis
Prof dr PMLA van den Bemt
Prof dr JJ de Gier
Information technology and medication safety
2018-11-30 Mirjam Simoons
Prof dr EN van Roon
Prof dr RA Schoevers
Somatic monitoring of patients with mood and anxiety disorders: Problem definition, implementation and further explorations
2018-09-14 Maarten van Wijhe
Prof dr MJ Postma
Prof dr J Wallinga
The public health impact of vaccination programmes in the Netherlands
2018-06-29 Ury Arifin
Prof dr MJ Postma
Distress and health-related quality of life in Indonesian type 2 diabetes mellitus outpatients
2018-06-25 Neily Zakiyah
Prof dr MJ Postma
Women's health from a global economic perspective
2018-03-23 Leàn Rolfes
Prof dr EP van Puijenbroek
Prof dr K Taxis
Patient participation in pharmacovigilance
2018-03-16 Thang Nuyen
Prof dr K Taxis
Prof dr B Wilffert
Prof de TT Pham
Medication use for acute coronary syndrome in Vietnam
2018-01-26 Eva van Doorn
Prof dr E Hak
Prof dr ALW Huckriede
Improving influenza prevention. Why universal influenza vaccines are needed
2017-08-12 Jurjen van der Schans
Prof dr E Hak
Prof dr PJ Hoekstra
Dr TW de Vries
ADHD and atopic diseases. Pharmacoepidemiological studies
2017-06-02 Jan Peter Yska
Prof dr EN van Roon
Prof dr B Wilffert
Exploring optimal pharmacotherapy after bariatric surgery: where two worlds meet
2017-04-24 Nur Aizati Athirah Daud
Prof dr B Wilffert
Dr JEH Bergman
Paving ways for personalizing drug therapy during pregnancy
2016-03-11 Maarten Bijlsma
Prof dr E Hak
Prof dr S Vansteelandt
Age-period-cohort methodology: Confounding by birth cohort in cardiovascular pharmacoepidemiology
2016-03-02 Linda de Jong
Prof dr IM van Langen
Prof dr LTW de Jong- van den Berg
Data quality and methodology in studies on maternal medication use in relation to congenital anomalies
2016-02-26 Dianna de Vries
Prof dr E Hak
Prof dr P Denig
Prof dr MJ Postma
Statin treatment in type 2 diabetes patients
2016-02-19 Bianca Mulder
Prof dr E Hak
Prof dr SS Jick
Medication use during pregnancy and atopic diseases in childhood
2016-01-25 Priscilla Zetstra-van der Woude
Prof dr LTW de Jong-van den Berg
Data collection on risk factors in pregnancy
2015-12-04 Koen Pouwels
Prof dr E Hak
Self-controlled designs to control confounding
2015-09-25 Job van Boven
Prof dr MJ Postma
Prof dr T van der Molen
Enhancing adherence in patients with COPD: Targets, interventions & cost-effectiveness
2014-05-28 Giedre Gefenaite
Prof dr E Hak
Prof dr RP Stolk
Newly introduced vaccines. Effectiveness and deterninants of acceptance
2013-05-31 Josta de Jong
Prof dr LTW de Jong-van den Berg
Dr TW de Vries
Antibiotic drug use in children. Pharmacoepidemiologic, practical, social en enviromental perspectives in the Netherlands
2013-02-25 Mark Rozenbaum
Prof dr MJ Postma
Prof dr E Hak
Cost and Effectiveness of Extended Vaccination Strategies against Pertussis and Pneumococcal Disease
2013-01-11 Peter ter Horst
Prof dr B Wilffert
Prof dr LTW de Jong-van den Berg
Clinical Pharmacology of Antidepressants During Pregnancy
2012-11-16 Ineke Crijns
Prof dr LTW de Jong-van den Berg
Drug Related Safety Issues Affecting Precnancy Outcome and Concerning Risk Minimisation Measures. Emphasis on Pregnancy Prevention Programmes
2012-03-16 Stefan Vegter
Prof dr MJ Postma
Prof dr G Navis
The value of personalized approaches to improve pharmacotherapy in renal disease
2012-02-24 Silvia Ravera
Prof dr JJ de Gier
Prof dr LTW de Jong vd berg
Psychotropic medications and traffic safety. Contributions to risk assessment and risk communication
2011-12-09 Janneke Boersma-Jentink
Prof dr LTW de Jong vd berg
Prof dr H Dolk
Risk assessment of antiepileptic drugs in pregnancy
2010-01-11 Marian K. Bakker
prof dr CHCM Buijs
Prof dr LTW de Jong van den berg
The use of a birth defects case-control monitoring system in studying the safety of medication use in pregnancy.
2009-06-12 Cornelis Boersma
Prof dr MJ Postma
Prof dr LTW de Jong van den berg
Prof dr PE de Jong
Health economics of cardiovascular & renal disease prevention : from clinical trials to real-life settings.
2009-03-20 Fokaline Vroom
Prof dr LTW de Jong-van den Berg
Prof dr JRBJ Brouwers
Prof dr MAFJ van de Laar
Drug use in pregnancy. Exploring the field of DMARDs in pregnancy.
2006-09-15 Jarir Atthobari
prof dr LTW de Jong-van den Berg
prof dr PE de Jong
Drug use in a population screening: Pharmacoepidemiological and pharmacoeconomical aspects.
2006-06-30 Rogier Klok
Prof dr JRBJ Brouwers
Prof dr MJ Postma
Pharmacoeconomic Analysis of Proton Pump Inhibitor Therapy and interventions to Control Helicobacter pylori Infection.
2006-10-02 Adrianne Faber
prof dr LTW de Jong-van den Berg
Stimulant treatment in children: a Dutch perspective.
2006-12-08 Willemijn Meijer
prof dr LTW de Jong-van den Berg
prof dr JRBJ Brouwers
Drug safety in pregnancy. Studying and communicating teratogenic risks.
2003-10-03 Claudia Rijcken
Prof dr LTW de Jong-van den Berg
Pharmacy Data as a Tool for assessing Antypsychotic Drug Use.
2003-10-03 Eric Schirm
Prof dr LTW de Jong-van den Berg
Dr H Tobi Drug
Exposure from conception till adulthood.